Call us for more information :+91-9879823319
GETIX Eye Drops 5 ml

GETIX Eye Drops 5 ml

Gatifloxacin 3 mg


Composition
Gatifloxacin 3 mg
Benzalkonium chloride (As preservative) NF 0.02% w/v
Sterile Aqueous vehicle q.s.

Dosage form
Ophthalmic Solution (Eye drops)

Description
Gatifloxacin is a 8-methoxy fluoroquinolone with a 3-methylpiperazinyl substituent at C7 inhibits DNA gyrase & topoisomerase IV.

Indications
Gatifloxacin ophthalmic solution is indicated for the treatment of bacterial conjunctivitis, keratitis, pre & post operatively to control the infection.

Dosage
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:Bacterial conjunctivitis: Instill one drop every two hours in the affected eye(s) f or 1st 2 days.Instill one drop up to four times daily from 3rd to 7th day. Pre operative: one drop 3 times a day 3 days before the surgery.

Contraindications
Gatifloxacin ophthalmic solution is contraindicated in patients with a history of hypersensitivity to gatifloxacin, to other quinolones, or to any of the components in this medication.

Warnings & precautions
NOT FOR INJECTION.
Gatifloxacin ophthalmic solution should not be injected subconjunctivally, nor should it be introduced directly into the anterior chamber of the eye. If an allergic reaction to gatifloxacin occurs, discontinue the drug. Serious acute hypersensitivity reactions may require immediate emergency treatment.

Pregnancy
Pregnancy Category C
Since there are no adequate and well-controlled studies in pregnant women, gatifloxacin solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Adverse effects The most frequently reported undesirable effects in the overall study population were conjunctival irritation, increased lacrimation, keratitis, and papillary conjunctivitis.

Storage
Store in a cool dry place. Protect from light.

Presentation
GETIX Eye drops is available in 5 ml FFS pack.

Home  |   About Us  |   Quality  |   Marketing  |   Products  |   Contact   

© Copyright 2014, All Right Reserved